In last trading session, Bioventus Inc (NASDAQ:BVS) saw 0.43 million shares changing hands with its beta currently measuring 0.86. Company’s recent per share price level of $6.79 trading at $0.25 or 3.82% at ring of the bell on the day assigns it a market valuation of $557.76M. That closing price of BVS’s stock is at a discount of -111.78% from its 52-week high price of $14.38 and is indicating a premium of 22.24% from its 52-week low price of $5.28. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.69 million shares which gives us an average trading volume of 421.31K if we extend that period to 3-months.
For Bioventus Inc (BVS), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 1.67. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Bioventus Inc (NASDAQ:BVS) trade information
Upright in the green during last session for gaining 3.82%, in the last five days BVS remained trading in the green while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $6.79 price level, adding 4.77% to its value on the day. Bioventus Inc’s shares saw a change of -35.33% in year-to-date performance and have moved 1.65% in past 5-day. Bioventus Inc (NASDAQ:BVS) showed a performance of -12.72% in past 30-days. Number of shares sold short was 0.97 million shares which calculate 2.67 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 15 to the stock, which implies a rise of 54.73% to its current value. Analysts have been projecting 15 as a low price target for the stock while placing it at a high target of 15. It follows that stock’s current price would drop -120.91% in reaching the projected high whereas dropping to the targeted low would mean a loss of -120.91% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -113.92% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 44.22% while estimates for its earnings growth in next 5 years are of 17.75%.
Bioventus Inc (NASDAQ:BVS)’s Major holders
Insiders are in possession of 11.51% of company’s total shares while institution are holding 72.01 percent of that, with stock having share float percentage of 81.38%. Investors also watch the number of corporate investors in a company very closely, which is 72.01% institutions for Bioventus Inc that are currently holding shares of the company. ESSEX WOODLANDS MANAGEMENT, INC. is the top institutional holder at BVS for having 13.02 million shares of worth $74.87 million. And as of 2024-06-30, it was holding 20.3278 of the company’s outstanding shares.
The second largest institutional holder is JUNIPER INVESTMENT COMPANY, LLC, which was holding about 6.83 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.6684 of outstanding shares, having a total worth of $39.29 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 1.03 shares of worth $7.0 million or 1.55% of the total outstanding shares. The later fund manager was in possession of 1.02 shares on Mar 31, 2025 , making its stake of worth around $6.91 million in the company or a holder of 1.53% of company’s stock.
